Schizophrenia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Schizophrenia stocks.

Schizophrenia Stocks Recent News

Date Stock Title
Apr 30 LLY Dow Jones Futures: Stock Market Skids Into Fed; Amazon Rises Late As AMD, Super Micro Plunge
Apr 30 LLY These 3 Companies Recently Lifted Guidance
Apr 30 NBIX UPDATE 2-Neurocrine Biosciences' Huntington's disease drug gets FDA approval
Apr 30 LLY REFILE-CORRECTED-US STOCKS-Wall Street stocks fall as markets weigh strong wage data, Fed meeting
Apr 30 NBIX Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules
Apr 30 LLY US STOCKS-Wall Street ends lower as markets weigh strong wage data, Fed meeting
Apr 30 VNDA Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
Apr 30 LLY US Equity Markets Close Down Tuesday After Higher Wage Data
Apr 30 LLY CORRECTED-US STOCKS-Wall Street stocks fall as markets weigh strong wage data, Fed meeting
Apr 30 LLY Sector Update: Health Care Stocks Mixed Late Afternoon
Apr 30 LLY US STOCKS-Wall Street stocks fall as markets weigh strong wage data, Fed meeting
Apr 30 LLY Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
Apr 30 LLY Stocks Keep Sinking, With Dow Losing 300 Points; IBD 50 Stock Hubbell Plunges
Apr 30 LLY Taxpayer to fork out £85bn to cover Bank of England losses
Apr 30 LLY Eli Lilly and Company (LLY) Q1 2024 Earnings Call Transcript
Apr 30 LLY Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024
Apr 30 LLY Potential for Weight-Loss Drugs Boosts Eli Lilly
Apr 30 LLY Lilly Soars as Forecast Boost Shows Weight-Loss Drugs’ Power
Apr 30 LLY IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Apr 30 AZN Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
Schizophrenia

Schizophrenia is a mental disorder characterized by abnormal behavior, strange speech and a decreased ability to understand reality. Other symptoms include false beliefs, unclear or confused thinking, hearing voices that do not exist, reduced social engagement and emotional expression and lack of motivation. People with schizophrenia often have additional mental health problems such as anxiety, depressive or substance-use disorders. Symptoms typically come on gradually, begin in young adulthood and in many cases never resolve.The causes of schizophrenia include environmental and genetic factors. Possible environmental factors include being raised in a city, cannabis use during adolescence, certain infections, the age of a person's parents, and poor nutrition during pregnancy. Genetic factors include a variety of common and rare genetic variants. Diagnosis is based on observed behavior, the person's reported experiences and reports of others familiar with the person. During diagnosis, a person's culture must also be taken into account. As of 2013, there is no objective test. Schizophrenia does not imply a "split personality" or dissociative identity disorder, conditions with which it is often confused in public perception.The mainstay of treatment is antipsychotic medication, along with counselling, job training and social rehabilitation. It is unclear whether typical or atypical antipsychotics are better. In those who do not improve with other antipsychotics, clozapine may be tried. In more serious situations where there is risk to self or others, involuntary hospitalization may be necessary, although hospital stays are now shorter and less frequent than they once were.About 0.3% to 0.7% of people are affected by schizophrenia during their lifetimes. In 2013, there were an estimated 23.6 million cases globally. Males are more often affected and on average experience more severe symptoms. About 20% of people eventually do well, and a few recover completely; about 50% have lifelong impairment. Social problems, such as long-term unemployment, poverty and homelessness, are common. The average life expectancy of people with the disorder is 10–25 years less than that of the general population. This is the result of increased physical health problems and a higher suicide rate (about 5%). In 2015, an estimated 17,000 people worldwide died from behavior related to, or caused by, schizophrenia.

Browse All Tags